Quality of Life Differences Between Responders and Non-responders in the Treatment of Cutaneous Lupus Erythematosus

Por Chang, Aileen Y., Ghazi, Elizabeth, Okawa, Joyce, Werth, Victoria P.
Publicado em 2013

Using the American College of Rheumatology and Systemic Lupus International Collaborating Clinics Criteria to Determine the Diagnosis of Systemic Lupus Erythematosus in Patients wi...

Por Tiao, Janice, Feng, Rui, Carr, Kasey, Okawa, Joyce, Werth, Victoria P.
Publicado no J Am Acad Dermatol (2016)

Comparative Study of Compounded Anesthetic Benzocaine/Lidocaine/Tetracaine (BLT) Cream with and without Abrasive Particles

Por Boonsiri, Metavee, Diaz, Deanna, Sukmee, Theerayuth, Okawa, Joyce, Ditre, Chérie M.
Publicado no J Clin Aesthet Dermatol (2017)

Oxygeneo(®)—A Unique Three-in-one Treatment of Exfoliation, Infusion, and Oxygenation via the Bohr Effect and TriPollar™ Radiofrequency for Skin Rejuvenation

Por Diaz, Deanna, Boonsiri, Metavee, Okawa, Joyce, Dekranes, Denise, Ditre, Chérie M.
Publicado no J Clin Aesthet Dermatol (2017)

A Cross-sectional Study of Untreated Depression and Anxiety in Cutaneous Lupus Erythematosus and Dermatomyositis

Por Achtman, Jordan, Kling, Mitchel A., Feng, Rui, Okawa, Joyce, Werth, Victoria P.
Publicado no J Am Acad Dermatol (2016)

Managing interventional clinical trials in the setting of COVID-19: Experience in an autoimmune skin disease unit

Por Borucki, Robert, Concha, Josef Symon S., Burroughs, Julie, Okawa, Joyce, Werth, Victoria P.
Publicado no JAAD Int (2020)

Interstitial lung disease in classic and clinically amyopathic dermatomyositis: a retrospective study with screening recommendations

Por Morganroth, Pamela A., Kreider, Mary Elizabeth, Okawa, Joyce, Taylor, Lynne, Werth, Victoria P.
Publicado em 2010

Reliability of the Autoimmune Bullous Disease Quality of Life (ABQOL) questionnaire in the United States

Por Sebaratnam, Deshan F, Okawa, Joyce, Payne, Aimee, Murrell, Dédée F, Werth, Victoria P
Publicado no Qual Life Res (2015)

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52 week trial

Por Okon, Lauren, Rosenbach, Misha, Krathen, Michael, Rose, Mathew, Propert, Kathleen, Okawa, Joyce, Werth, Victoria
Publicado no J Am Acad Dermatol (2014)

Evaluating the impact of prior authorizations in patients with complex dermatological conditions

Por Jew, Olivia S., Okawa, Joyce, Barbieri, John S., McCaffrey, Joanne, Hayward, Elizabeth, Werth, Victoria P.
Publicado no J Am Acad Dermatol (2020)

Prevalence of Self-report Photosensitivity in Cutaneous Lupus Erythematosus

Por Foering, Kristen, Goreshi, Renato, Klein, Rachel, Okawa, Joyce, Rose, Mathew, Cucchiara, Andrew, Werth, Victoria P.
Publicado em 2011

Characterization of clinical photosensitivity in cutaneous lupus erythematosus

Por Foering, Kristen, Chang, Aileen Y., Piette, Evan W., Cucchiara, Andrew, Okawa, Joyce, Werth, Victoria P.
Publicado em 2013

Lenalidomide for the Treatment of Resistant Discoid Lupus Erythematosus

Por Shah, Asha, Albrecht, Joerg, Bonilla-Martinez, Zuleika, Okawa, Joyce, Rose, Mathew, Rosenbach, Misha, Werth, Victoria P.
Publicado em 2009

QoL and disease severity in a CLE pilot study

Por Gaines, Elizabeth, Bonilla-Martinez, Zuleika, Albrecht, Joerg, Taylor, Lynne, Okawa, Joyce, Troxel, Andrea B., Werth, Victoria
Publicado em 2008

Quality of life in dermatomyositis

Por Goreshi, Renato, Chock, Monika, Foering, Kristen, Feng, Rui, Okawa, Joyce, Rose, Matt, Fiorentino, David, Werth, Victoria
Publicado em 2011

Cross-sectional analysis of a collaborative web-based database for lupus erythematosus associated skin lesions: 114 prospectively enrolled patients

Por Moghadam-Kia, Siamak, Chilek, Katherine, Gaines, Elizabeth, Costner, Melissa, Rose, Mathew E., Okawa, Joyce, Werth, Victoria P.
Publicado em 2009

Response to Antimalarials in Cutaneous Lupus Erythematosus A Prospective Analysis

Por Chang, Aileen Y., Piette, Evan W., Foering, Kristen P., Tenhave, Thomas R., Okawa, Joyce, Werth, Victoria P.
Publicado em 2011

The Cutaneous Lupus Erythematosus Disease Area and Severity Index: A Responsive Instrument to Measure Activity and Damage in Patients With Cutaneous Lupus Erythematosus

Por Bonilla-Martinez, Zuleika L., Albrecht, Joerg, Troxel, Andrea B., Taylor, Lynne, Okawa, Joyce, Dulay, Sam, Werth, Victoria P.
Publicado em 2008

Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus

Por Klein, Rachel, Moghadam-Kia, Siamak, LoMonico, Jonathan, Okawa, Joyce, Coley, Chris, Taylor, Lynne, Troxel, Andrea B., Werth, Victoria
Publicado em 2011

Quality of Life in Cutaneous Lupus Erythematosus

Por Klein, Rachel, Moghadam-Kia, Siamak, Taylor, Lynne, Coley, Christopher, Okawa, Joyce, LoMonico, Jonathan, Chren, Mary-Margaret, Werth, Victoria P.
Publicado em 2011